Welcome to
Prepytid
Understand peptides.
Research smarter.
The peptide therapeutics market is on a trajectory toward $294.6 billion by 2033. As interest in BPC-157, TB-500, and GLP-1 grows faster than quality information, evidence-based education has never mattered more.
The landscape by the numbers
$294.6B
Projected market by 2033
Up from $140.9B in 2025
1 in 8
Americans on GLP-1 peptides
A rapidly expanding segment
43.5%
GLP-1 users report side effects
Underscoring the need for education
60%
U.S. adults use supplements
Yet quality information stays scarce
Why Prepytid
Quality information is scarce.
We bridge the gap.
Evidence-Based Education
Every answer is grounded in published research — not anecdote. Mechanism, application, and context, clearly explained.
Safety-First Framing
Side effects, contraindications, and researcher safety protocols are surfaced automatically — never buried.
Stack Intelligence
Understand which compounds are studied together, what synergies researchers have observed, and what interactions to consider.
Compound library
Commonly researched
peptide compounds
BPC-157
Repair & RecoveryBody Protection Compound. Studied for tissue regeneration, gut health, and tendon repair.
TB-500
Mobility & HealingThymosin Beta-4 fragment. Explored for accelerated wound healing and inflammation reduction.
GHK-Cu
Skin & RegenerationCopper peptide tripeptide. Researched for collagen synthesis and tissue remodeling.
CJC-1295
Growth HormoneGHRH analogue studied for its prolonged growth hormone-releasing effects.
GLP-1
MetabolicGlucagon-like peptide-1 agonists. Widely studied for metabolic regulation and appetite signaling.
Ipamorelin
SecretagogueSelective growth hormone secretagogue with minimal off-target effects in research models.
Get started
Research with confidence.
With 1 in 8 Americans already using GLP-1 peptide medications and 43.5% experiencing side effects, informed decision-making has never mattered more.